If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

Share Price is delayed by 15 minutes
Get Live Data
1.795    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.05 (2.825%)
Market Cap: $74.93m
LSAA Live PriceLast checked at - London Stock Exchange

Intraday Life Settlemen Share Chart

Portfolio Update - Update on MBC finalisation

28 Mar 2025 11:45

RNS Number : 7291C
Life Settlement Assets PLC
28 March 2025
 

This announcement contains inside information

 

Life Settlement Assets PLC (the "Company" or "LSA")

LEI: 2138003OL2VBXWG1BZ27

Update on MBC finalisation

The Company provides an update on the finalisation of the absorption of the MBC portfolio in the Company's asset base.

LSA, the closed end investment trust which manages portfolios of whole interests in life settlement policies issued by life insurance companies, has made steady progress during 2024 on the finalisation of administrative arrangements relating to the MBC action. During 2024 the Company reported that on 28 August 2024 it received notification that funds amounting to USD 9.7 million had been received by the Company, comprising the first tranche of the MBC sale proceeds of USD 5.7 million and the return of overpaid premiums of USD 4.0 million. The impact of this refund was reflected in the 31 July 2024 Net Asset Value of USD 2.33 per share released to the market on 16 September 2024.

The second and final tranche of the MBC sale proceeds of up to USD 6.0 million is expected to be received by the Company during 2025 and has previously been included in the Company's NAV.

However, since the year end further examination of the portfolio acquired from the MBC Trustee by LSA's Investment Manager has revealed that the MBC Trustee had previously not exercised an extension to a particular policy which extended the maturity from 100 to 120 years. This is likely to have a detrimental impact on the NAV of USD 3-4%. A further announcement regarding this will be made in due course.

Michael Baines, Chairman of LSA, said, "This news relating to a previous decision taken by the MBC Trustee is disappointing, and it underlines the correctness of our strategy to take full control of all our policies, removing the dependence on external third parties to maintain the value in our policies. Despite the decision taken by the MBC Trustee, the results of the acquisition have been very favourable for the Company."

 

For further information, please contact:

Acheron Capital Limited (Investment Manager)

Jean-Michel Paul

020 7258 5990

 

Shore Capital (Financial Adviser and Broker)

Gillian Martin / Anita Ghanekar / Harry Davies-Ball

020 7408 4090

 

ISCA Administration Services Limited (the Company Secretary) on

01392 487056; or lsa@iscaadmin.co.uk

 

28 March 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUJPMBTMTJTBFA
Date   Source Headline
13th Jun 20241:13 pmRNSNet Asset Value(s)
13th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSShare buy-back programme
3rd Jun 20247:00 amRNSNet Asset Value(s)
21st May 20247:00 amRNSNet Asset Value(s)
20th May 20244:11 pmRNSNet Asset Value(s)
30th Apr 20243:31 pmRNSFinal Results
1st Mar 20244:13 pmRNSPolicy Maturities
1st Mar 20243:40 pmRNSNet Asset Value(s)
15th Feb 20243:00 pmRNSDividend Declaration
2nd Feb 20244:15 pmRNSNet Asset Value(s)
24th Jan 20249:54 amRNSNet Asset Value(s)
20th Dec 20237:00 amRNSPolicy Maturities and update on MBC settlement
13th Dec 202310:35 amRNSHolding(s) in Company
13th Nov 20239:34 amRNSNet Asset Value(s)
17th Oct 20235:14 pmRNSNet Asset Value(s)
27th Sep 20237:00 amRNSHalf-year Report
20th Sep 202311:53 amRNSNet Asset Value(s)
18th Aug 20239:52 amRNSNet Asset Value(s)
17th Jul 20231:06 pmRNSNet Asset Value(s)
14th Jun 20234:14 pmRNSAGM Statement
2nd Jun 202310:17 amRNSNet Asset Value(s)
30th May 202312:33 pmRNSNet Asset Value(s)
16th May 202312:26 pmRNSNet Asset Value(s)
28th Apr 20237:00 amRNSFinal Results
5th Apr 20239:33 amRNSNet Asset Value(s)
5th Apr 20237:00 amRNSUpdate on MBC Auction
6th Mar 20233:22 pmRNSHolding(s) in Company
6th Mar 20237:00 amRNSUpdate on MBC Auction
23rd Feb 20233:25 pmRNSNet Asset Value(s)
23rd Feb 20231:56 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSDividend Declaration
27th Jan 20234:44 pmRNSUpdate on MBC Auction
16th Jan 202311:40 amRNSNet Asset Value(s)
30th Dec 20227:00 amRNSUpdate on MBC Auction
12th Dec 20227:00 amRNSUpdate on MBC Auction
5th Dec 20222:40 pmRNSStatement re MBC Auction
2nd Dec 20226:21 pmRNSNet Asset Value(s)
14th Nov 202211:24 amRNSNet Asset Value(s)
29th Sep 20223:42 pmRNSNet Asset Value(s)
28th Sep 20227:00 amRNSHalf-year Report
8th Sep 20221:32 pmRNSNet Asset Value(s)
10th Aug 202210:09 amRNSNet Asset Value(s)
12th Jul 20225:35 pmRNSHolding(s) in Company
7th Jul 202212:07 pmRNSNet Asset Value(s)
30th Jun 20227:00 amRNSStatement re agreement to reduce performance fee
23rd Jun 20224:22 pmRNSResult of Annual General Meeting
22nd Jun 20224:56 pmRNSNet Asset Value(s)
26th May 202210:56 amRNSNet Asset Value(s)
23rd May 20222:16 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.